Morepen Laboratories Q1 FY27 Analysis: Strong Growth Across Sales, Profitability, and Earnings
Morepen Laboratories has reported an impressive set of quarterly numbers for June 2026, demonstrating strong growth across revenue, operating profit, net profit, and earnings per share. The results indicate that the company has not only expanded its top line but has also significantly improved operational efficiency and profitability.
Revenue Continues to Grow
The company reported sales of ₹570 crore during the June 2026 quarter.
- June 2026 Sales: ₹570 crore
- March 2026 Sales: ₹484 crore
- June 2025 Sales: ₹425 crore
This represents:
- 17.62% Quarter-on-Quarter (QoQ) growth
- 34.07% Year-on-Year (YoY) growth
Adding nearly ₹86 crore in revenue over the previous quarter and ₹145 crore over the same quarter last year reflects healthy business momentum. Double-digit growth in both sequential and annual comparisons suggests strong demand and sustained business expansion.
Operating Profit Shows Exceptional Improvement
The most striking aspect of the results is the sharp jump in operating profit.
| Quarter | Operating Profit |
|---|---|
| Jun 2025 | ₹24.17 crore |
| Mar 2026 | ₹24.45 crore |
| Jun 2026 | ₹82.53 crore |
Growth:
- 237% QoQ
- 241% YoY
Operating profit increased by more than ₹58 crore compared to the previous quarter. While revenue rose by about 18%, operating profit expanded by well over three times, indicating a significant improvement in operating leverage.
Such performance often points toward one or more of the following:
- Better product mix
- Higher manufacturing efficiency
- Lower input costs
- Improved pricing power
- Better capacity utilization
Regardless of the underlying reason, profitability has expanded much faster than revenue.
Operating Margin Expansion
Operating margin has improved dramatically.
June 2025
Operating Margin:
₹24.17 crore ÷ ₹425 crore = 5.69%
March 2026
₹24.45 crore ÷ ₹484 crore = 5.05%
June 2026
₹82.53 crore ÷ ₹570 crore = 14.48%
The operating margin has therefore increased from around 5% to nearly 14.5%, representing a major improvement in business efficiency.
Net Profit Nearly Quadruples
Net profit delivered another outstanding performance.
| Quarter | Net Profit |
|---|---|
| Jun 2025 | ₹11.40 crore |
| Mar 2026 | ₹15.70 crore |
| Jun 2026 | ₹56.35 crore |
Growth:
- 258% QoQ
- 394% YoY
Compared with the previous year, profits have increased almost fivefold.
Sequentially, the company generated approximately ₹40.65 crore additional profit in just one quarter.
This level of earnings acceleration is substantially stronger than revenue growth and highlights a sharp improvement in the company’s overall profitability.
Net Profit Margin Improves Significantly
Net margins have expanded considerably.
June 2025
₹11.40 crore ÷ ₹425 crore = 2.68%
March 2026
₹15.70 crore ÷ ₹484 crore = 3.24%
June 2026
₹56.35 crore ÷ ₹570 crore = 9.89%
Net profit margin has therefore increased from less than 3% a year ago to nearly 10%.
This indicates that a much larger share of every rupee of sales is now translating into bottom-line earnings.
EPS Growth Mirrors Profit Growth
Earnings per Share (EPS) also improved substantially.
| Quarter | EPS |
|---|---|
| Jun 2025 | 0.20 |
| Mar 2026 | 0.29 |
| Jun 2026 | 1.03 |
Growth:
- 258% QoQ
- 424% YoY
Crossing the ₹1 EPS mark after reporting ₹0.20 in the same quarter last year represents a significant increase in shareholder earnings.
Growth Summary
| Metric | QoQ Growth | YoY Growth |
|---|---|---|
| Sales | 17.62% | 34.07% |
| Operating Profit | 237% | 241% |
| Net Profit | 258% | 394% |
| EPS | 258% | 424% |
The data clearly shows that profit growth has been substantially higher than revenue growth. This usually indicates that the company is benefiting from improving operating leverage and stronger cost management rather than relying solely on higher sales.
Valuation Snapshot
The company currently has:
- Market Capitalization: ₹3,164 crore
- Price-to-Earnings (PE) Ratio: 33.35
A PE of around 33 suggests that investors are assigning a premium valuation relative to current earnings. Following such a strong earnings report, market participants will likely focus on whether the company can sustain this higher level of profitability over the coming quarters.
Key Takeaways
The June 2026 quarter marks one of the strongest performances in recent periods for Morepen Laboratories. Revenue expanded at a healthy pace, but the real highlight was the sharp improvement in profitability. Operating profit more than tripled, net profit increased almost fivefold compared to the previous year, and both operating and net margins expanded significantly.
If the company can maintain revenue growth while preserving its improved margins, it could continue delivering strong earnings growth in future quarters. Investors will likely monitor upcoming results to determine whether this quarter represents the beginning of a sustained improvement in operational performance or an exceptionally strong standalone quarter.